Rituximab progressive multifocal

Rituximab CD20 Non-Hodgkins lymphoma Fever, infusion reactions, tumor lysis syndrome, infections, progressive multifocal leukoencephalopathy (PML)... [Pg.455]

Nervous system There is increasing evidence of a possible association of rituximab with progressive multifocal leukoencephalo-pathy through reactivation of JC polyoma-virus [152 ]. [Pg.594]

Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, Bennett CL. Monoclonal antibody-associated progressive multifocal leucoen-cephalopathy in patients treated with rituximab, natalizumab, and efalizumab a Review from the Research on Adverse Drug Events and Reports (RADAR) Project. Lancet Oncol 2009 10(8) 816-24. [Pg.605]

Rituximab (Rituxan/ MabThera) CD20 1997 Not conducted No information 2-month monkey B-cell depletion Tumor lysis syndrome (TLS), progressive multifocal leukoencephalopathy (PML), hepatitis B, infections, cardiac arrhythmias and angina, bowel obstruction and perforation, cytopenias... [Pg.419]

Nervous system Rituximab can be associated with an increased risk of progressive multifocal leukoencephalopathy [294, 295 ]. [Pg.792]

Fleischmann RM. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis. Arthritis Rheum 2009 60 3225-8. [Pg.812]

Big Chemical Encyclopedia